St Luke's Hospital, Singapore

M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials

Retrieved on: 
월요일, 9월 18, 2023
Chin Na, Amputation, The New England Journal of Medicine, M&L, CE marking, Type 2 diabetes, Catheter, Johannes Hoffmann (vascular surgeon), Vein, Statistics, COVID-19, Clinical trial, Foot, Quality of life, St Luke's Hospital, Singapore, Leg, Artery, Changi General Hospital, Elective surgery, PMA, Transcatheter arterial chemoembolization, Patient, Investment, MD, Series, Engineering, Mortality, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Medtech, Food, Wound healing, Pharmaceutical industry, Medical device, Valvulotome, EU, CLTI

The approval comes after successful outcomes in the PROMISE II Pivotal trial in the United States, recently published in the New England Journal of Medicine.

Key Points: 
  • The approval comes after successful outcomes in the PROMISE II Pivotal trial in the United States, recently published in the New England Journal of Medicine.
  • It is the first and only FDA-approved device for TADV and provides no-option CLTI patients with access to a minimally invasive treatment.
  • Type 2 diabetes is a major cause of CLTI, a condition that affects millions of people globally.
  • The United States alone witnesses approximately 150,000 ischemic amputations each year, resulting in healthcare costs of over US$95 billion.

St. Luke's Reduces Discharge Delays with Parachute Health DME ePrescribing

Retrieved on: 
목요일, 2월 9, 2023
Insurance, Partnership, Parachute, St Luke's, DME, Patient, SVP, St Luke's Hospital, Singapore, University Health Network, EHR, Case management (US healthcare system), Electronic health record, Case management, COVID, Love, Luke the Evangelist, Nursing

In 2021, SLUHN completed electronic health record (EHR) integration of Parachute Health's ePrescribing platform for DME and supplies.

Key Points: 
  • In 2021, SLUHN completed electronic health record (EHR) integration of Parachute Health's ePrescribing platform for DME and supplies.
  • Now, SLUHN reports significant improvements in discharge workflows on the Parachute Platform, which replaced time-consuming and error-prone order faxing.
  • Pollinger hopes to see more health plans and "payviders" work directly with Parachute Health: "This is a key opportunity for health plans to be drivers of positive change while optimizing their business value and patient outcomes."
  • "At St. Luke's, the paperwork associated with qualifying an order was a massive barrier for getting patients the timely DME they needed," Dustin Eubanks, SVP of Partnerships at Parachute Health, noted about St. Luke's switch to ePrescribing.